CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.91 +0.00 (+0.00%)
As of: Oct 22, 2026 · 3:59 PM EDT

CytoMed Therapeutics (GDTC) Minority Interest (2021 - 2026)

Updated

CytoMed Therapeutics' Minority Interest was $426,592 in Q2 2026, up 463.7% from $75,681 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Minority Interest (2021 - 2026) Analysis & Trends

At the end of FY2025, Minority Interest at CytoMed Therapeutics came in at $309,221, up 297.7% from FY2024.

  • In earlier years, Minority Interest was $77,749 in FY2024, -$956.00 in FY2023, -$682.00 in FY2022 and -$439.00 in FY2021.
  • The Q2 2026 figure marks the highest quarterly Minority Interest in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 CytoMed Therapeutics 10.46 Mn 855,548.76 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 426,592.00
Dec 31, 2025 309,221.00
Jun 30, 2025 75,681.00
Dec 31, 2024 77,749.00
Jun 30, 2024 -1,101.00
Dec 31, 2023 -956.00
Jun 30, 2023 -822.00
Dec 31, 2022 -682.00
Dec 31, 2021 -439.00
API Access

CytoMed Therapeutics Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=GDTC&period=max&api_key=YOUR_API_KEY